Paper · 1756902
Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
Ludvik B and 4 others. Diabetes, 1991. Cited by 84 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Papers, record 1756902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1756902
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid | Major topic |
| Blood Glucose | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Insulin | Major topic |
| Adult | |
| Biomarkers | |
| Glucose Tolerance Test | |
| Humans | |
| Insulin Secretion | |
| Islet Amyloid Polypeptide | |
| Kinetics | |
| Obesity | |
| Prediabetic State | |
| Radioimmunoassay | |
| Reference Values | |
| Time Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,708,975 | The story of amylin: from physiology to therapy. | Nat Metab | 2026 | https://conductscience.org/library/papers/41708975 | PubMed |
| 41,575,482 | Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. | Curr Obes Rep | 2026 | https://conductscience.org/library/papers/41575482 | PubMed |
| 39,028,826 | Decreased islet amyloid polypeptide staining in the islets of insulinoma patients. | Islets | 2024 | https://conductscience.org/library/papers/39028826 | PubMed |
| 38,338,796 | Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338796 | PubMed |
| 35,456,307 | Mediators of Amylin Action in Metabolic Control. | J Clin Med | 2022 | https://conductscience.org/library/papers/35456307 | PubMed |
| 33,488,526 | Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33488526 | PubMed |
| 28,702,246 | Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials. | Clin Diabetes Endocrinol | 2016 | https://conductscience.org/library/papers/28702246 | PubMed |
| 25,750,761 | Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment. | J Diabetes Metab | 2014 | https://conductscience.org/library/papers/25750761 | PubMed |
| 21,664,909 | PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21664909 | PubMed |
| 21,319,343 | Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome. | Yonsei Med J | 2011 | https://conductscience.org/library/papers/21319343 | PubMed |
1 to 10 of 19
See all 19 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IAPP | 3,375 | PubTator's text mining | https://conductscience.org/library/genes/3375 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1756902
GET https://conductscience.org/api/papers/v1/1756902/authors